Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Datasets
Search by expertise, name or affiliation
Targeting the p53 signaling pathway in cancer therapy the promises, challenges and perils
Alexander H. Stegh
*
*
Corresponding author for this work
Neurology
Research output
:
Contribution to journal
›
Review article
›
peer-review
150
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Targeting the p53 signaling pathway in cancer therapy the promises, challenges and perils'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Protein P53
100%
Malignant Neoplasm
43%
Neoplasm
18%
DNA
6%
Organisms
6%
Transcription Factor
6%
Cancer Growth
6%
Mutant Protein
6%
Cellular Processes
6%
Death
6%
Growth Disorder
6%
Survival
6%
Drug Development
6%
Tumor Suppressor Protein
6%
INIS
cancer
50%
tumors
25%
therapy
18%
aging
6%
humans
6%
drugs
6%
growth
6%
proteins
6%
biology
6%
homeostasis
6%
death
6%
mutants
6%
transcription factors
6%
inactivation
6%
dna repair
6%